The IPO market is taking a break during the shortened Thanksgiving week, with just one IPO and a few SPACs scheduled to raise at least $900 million.
Russian e-commerce company Ozon Holdings (OZON) plans to raise $750 million at a $4.4 billion market cap. Backed by private equity firm Baring Vostok and Russian conglomerate Sistema, Ozon is a direct play on the...read more
Eleven IPOs and nine SPACs priced this past week, getting out ahead of the US election. Markets tumbled and volatility spiked, as several deals broke issue and three IPOs postponed. The diverse group had very mixed trading, and averaged a return of 9.9%. New filings kept steady with six IPOs and five SPACs (...read more
Galecto, a phase 2 biotech developing therapeutics for fibrosis and related diseases, raised $85 million by offering 5.7 million shares at $15, the midpoint of its range of $14 to $16. Galecto's initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, which play key roles in regulating fibrosis. Its lead product...read more
Updated Monday, 10/26. In a pre-election tidal wave of deals, 15 IPOs are scheduled to raise $5.1 billion in the week ahead. Chinese loan facilitation platform Lufax (LU) is leading the diverse group, which includes a pool supplies retailer, an mobile auto insurer, and two mortgage lenders, among others. The largest deal of the week,...read more
US IPO Week Ahead: The IPO market takes a break during the shortened holiday week
The IPO market is taking a break during the shortened Thanksgiving week, with just one IPO and a few SPACs scheduled to raise at least $900 million. Russian e-commerce company Ozon Holdings (OZON) plans to raise $750 million at a $4.4 billion market cap. Backed by private equity firm Baring Vostok and Russian conglomerate Sistema, Ozon is a direct play on the...read more
US IPO Weekly Recap: Big fintechs fall as 11 IPOs squeeze in ahead of the election
Eleven IPOs and nine SPACs priced this past week, getting out ahead of the US election. Markets tumbled and volatility spiked, as several deals broke issue and three IPOs postponed. The diverse group had very mixed trading, and averaged a return of 9.9%. New filings kept steady with six IPOs and five SPACs (...read more
Fibrosis biotech Galecto prices $85 million IPO at $15 midpoint
Galecto, a phase 2 biotech developing therapeutics for fibrosis and related diseases, raised $85 million by offering 5.7 million shares at $15, the midpoint of its range of $14 to $16. Galecto's initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, which play key roles in regulating fibrosis. Its lead product...read more
US IPO Week Ahead: Chinese fintech, pool supplies, and auto insurance lead a diverse 15 IPO week
Updated Monday, 10/26. In a pre-election tidal wave of deals, 15 IPOs are scheduled to raise $5.1 billion in the week ahead. Chinese loan facilitation platform Lufax (LU) is leading the diverse group, which includes a pool supplies retailer, an mobile auto insurer, and two mortgage lenders, among others. The largest deal of the week,...read more